This is the authors' abstract. We don't add key points for this paper.
PURPOSE: C-lifitegrast mass balance/excretion in dogs. METHODS: ). RESULTS: C-lifitegrast was eliminated primarily through feces. Excreted radioactivity was mainly unchanged lifitegrast. CONCLUSIONS: C-lifitegrast suggests minimal drug metabolism in vivo. This is consistent with lifitegrast clinical trial efficacy/safety data.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: